Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials.

Lee, Seung-Yul; Hong, Myeong-Ki; Palmerini, Tullio; Kim, Hyo-Soo; Valgimigli, Marco; Feres, Fausto; Colombo, Antonio; Gilard, Martine; Shin, Dong-Ho; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Jang, Yangsoo; Stone, Gregg W (2018). Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials. JACC. Cardiovascular Interventions, 11(5), pp. 435-443. Elsevier 10.1016/j.jcin.2017.10.015

[img] Text
2018 JACC Cardiovasc Interv_Lee.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (753kB) | Request a copy

OBJECTIVES This study sought to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after the implantation of a drug-eluting stent (DES) in elderly patients. BACKGROUND Qualified studies to evaluate the optimal duration of DAPT in elderly patients have been very limited. METHODS Using 6 randomized trials that compared short-term (≤6 months) and long-term (12 months) DAPT, individual participant data meta-analysis was performed in elderly patients (≥65 years of age). The primary study outcome was the 12-month risk of a composite of myocardial infarction, definite or probable stent thrombosis, or stroke. The major secondary outcome was the 12-month risk of major bleeding. RESULTS The primary outcome risk did not significantly differ between patients receiving short-term and long-term DAPT (hazard ratio [HR]: 1.12; 95% confidence interval [CI]: 0.88 to 1.43; p = 0.3581) in the overall group of study participants. In subgroup analysis, a significant interaction between age and DAPT duration was observed for primary outcome risk (p for interaction = 0.0384). In the subset of younger patients (<65 years of age, n = 6,152), short-term DAPT was associated with higher risk of primary outcome (HR: 1.67; 95% CI: 1.14 to 2.44; p = 0.0082). In elderly patients (n = 5,319), however, the risk of primary outcome did not significantly differ between patients receiving short-term and long-term DAPT (HR: 0.84; 95% CI: 0.60 to 1.16; p = 0.2856). Short-term DAPT was associated with a significant reduction in major bleeding compared with long-term DAPT (HR: 0.50; 95% CI: 0.30 to 0.84; p = 0.0081) in the overall group, and particularly in elderly patients (HR: 0.46; 95% CI: 0.24-0.88; p = 0.0196). CONCLUSIONS Short-term DAPT after new-generation DES implantation may be more beneficial in elderly patients than in younger patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Valgimigli, Marco

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1876-7605

Publisher:

Elsevier

Language:

English

Submitter:

Amanda Valle

Date Deposited:

02 Aug 2018 15:22

Last Modified:

02 Aug 2018 15:22

Publisher DOI:

10.1016/j.jcin.2017.10.015

PubMed ID:

29454730

Uncontrolled Keywords:

coronary artery disease drug-eluting stent(s) dual antiplatelet therapy

BORIS DOI:

10.7892/boris.119031

URI:

https://boris.unibe.ch/id/eprint/119031

Actions (login required)

Edit item Edit item
Provide Feedback